
Biography
JASON NELSON focuses his practice on complex business transactions, including mergers and acquisitions, private equity investments, and corporate governance matters.
While attending the University of Virginia School of Law, Jason served as an editorial board member of the Virginia Tax Review. He has also passed Level I of the Chartered Financial Analyst® (CFA) Program.
Experience
Representative Matters
- PepStar Therapeutics Limited, a privately held, clinical-stage biotechnology company, in its definitive agreement to sell its investigational oral IL-23 receptor (IL-23R) inhibitor program, including lead asset HCXT-2001, to Gilead Sciences, Inc. for US$1.275 billion.
Credentials
Admissions & Certifications
- New York
Education
- University of Virginia School of Law, J.D., 2024
- Union College, B.S., 2020